Hans-Jürgen Möller, MD

Original Research

Different Effects of Mirtazapine and Venlafaxine on Brain Activation: An Open Randomized Controlled fMRI Study

September 21, 2010

Thomas Frodl, Johanna Scheuerecker, Veronika Schoepf, et al

Original Research

Suicidality as Rare Adverse Event of Antidepressant Medication: Report From the AMSP Multicenter Drug Safety Surveillance Project

August 10, 2010

Susanne Stübner, Renate Grohmann, Irmela von Stralendorff, et al

Original Research

Do Efficacy and Effectiveness Samples Differ in Antidepressant Treatment Outcome? An Analysis of Eligibility Criteria in Randomized Controlled Trials

August 10, 2010

Florian Seemüller, Hans-Jürgen Möller, Michael Obermeier, et al

Original Research

Prevalence and Treatment Outcome in Anxious Versus Nonanxious Depression: Results From the German Algorithm Project

July 13, 2010

Katja Wiethoff, Michael Bauer, Thomas C. Baghai, et al

Original Research

Relapse Prevention in First-Episode Schizophrenia—Maintenance vs Intermittent Drug Treatment With Prodrome-Based Early Intervention: Results of a Randomized Controlled Trial Within the German Research Network on Schizophrenia

June 29, 2010

Wolfgang Gaebel, Mathias Riesbeck, Wolfgang Wölwer, et al

Article

Lithium Trial in Alzheimer's Disease: A Randomized, Single-Blind, Placebo-Controlled, Multicenter 10-Week Study

June 18, 2009

Harald Hampel, Michael Ewers, Katharina Bürger, et al

Original Research

The Impact of Reboxetine and Mirtazapine on Driving Simulator Performance and Psychomotor Function in Depressed Patients

December 31, 2008

Alexander Brunnauer, Gerd Laux, Irmgard David, et al

Original Research

The Impact of Homocysteine Levels on Cognition in Euthymic Bipolar Patients: A Cross-Sectional Study

June 30, 2008

Sandra Dittmann, Florian Seemüller, Heinz C. Grunze, et al

Original Research

Maintenance Treatment With Risperidone or Low-Dose Haloperidol in First-Episode Schizophrenia: 1-Year Results of a Randomized Controlled Trial Within the German Research Network on Schizophrenia

November 15, 2007

Wolfgang Gaebel, Mathias Riesbeck, Wolfgang Wölwer, et al

Original Research

Antidepressants and Driving Ability: Results From a Clinical Study

November 15, 2006

Alexander Brunnauer, Gerd Laux, Elisabeth Geiger, et al

Original Research

Hippocampal and Amygdala Changes in Patients With Major Depressive Disorder and Healthy Controls During a 1-Year Follow-Up

April 1, 2004

Thomas Frodl, Eva M. Meisenzahl, Thomas Zetzsche, et al

Original Research

Negative Symptoms in Depressed and Schizophrenic Patients: How Do They Differ?

August 15, 2003

Ronald Bottlender, Tetsuya Sato, Constanze Groll, et al

Different Effects of Mirtazapine and Venlafaxine on Brain Activation: An Open Randomized Controlled fMRI Study

Suicidality as Rare Adverse Event of Antidepressant Medication: Report From the AMSP Multicenter Drug Safety Surveillance Project

Do Efficacy and Effectiveness Samples Differ in Antidepressant Treatment Outcome? An Analysis of Eligibility Criteria in Randomized Controlled Trials

Prevalence and Treatment Outcome in Anxious Versus Nonanxious Depression: Results From the German Algorithm Project

Relapse Prevention in First-Episode Schizophrenia—Maintenance vs Intermittent Drug Treatment With Prodrome-Based Early Intervention: Results of a Randomized Controlled Trial Within the German Research Network on Schizophrenia

Lithium Trial in Alzheimer's Disease: A Randomized, Single-Blind, Placebo-Controlled, Multicenter 10-Week Study

The Impact of Reboxetine and Mirtazapine on Driving Simulator Performance and Psychomotor Function in Depressed Patients

The Impact of Homocysteine Levels on Cognition in Euthymic Bipolar Patients: A Cross-Sectional Study

Maintenance Treatment With Risperidone or Low-Dose Haloperidol in First-Episode Schizophrenia: 1-Year Results of a Randomized Controlled Trial Within the German Research Network on Schizophrenia

Antidepressants and Driving Ability: Results From a Clinical Study

Hippocampal and Amygdala Changes in Patients With Major Depressive Disorder and Healthy Controls During a 1-Year Follow-Up

Negative Symptoms in Depressed and Schizophrenic Patients: How Do They Differ?

ELSEWHERE:

FOLLOW US:

Hans-Jürgen Möller, MD

Different Effects of Mirtazapine and Venlafaxine on Brain Activation: An Open Randomized Controlled fMRI Study

Suicidality as Rare Adverse Event of Antidepressant Medication: Report From the AMSP Multicenter Drug Safety Surveillance Project

Do Efficacy and Effectiveness Samples Differ in Antidepressant Treatment Outcome? An Analysis of Eligibility Criteria in Randomized Controlled Trials

Prevalence and Treatment Outcome in Anxious Versus Nonanxious Depression: Results From the German Algorithm Project

Relapse Prevention in First-Episode Schizophrenia—Maintenance vs Intermittent Drug Treatment With Prodrome-Based Early Intervention: Results of a Randomized Controlled Trial Within the German Research Network on Schizophrenia

Lithium Trial in Alzheimer's Disease: A Randomized, Single-Blind, Placebo-Controlled, Multicenter 10-Week Study

The Impact of Reboxetine and Mirtazapine on Driving Simulator Performance and Psychomotor Function in Depressed Patients

The Impact of Homocysteine Levels on Cognition in Euthymic Bipolar Patients: A Cross-Sectional Study

Maintenance Treatment With Risperidone or Low-Dose Haloperidol in First-Episode Schizophrenia: 1-Year Results of a Randomized Controlled Trial Within the German Research Network on Schizophrenia

Antidepressants and Driving Ability: Results From a Clinical Study

Hippocampal and Amygdala Changes in Patients With Major Depressive Disorder and Healthy Controls During a 1-Year Follow-Up

Negative Symptoms in Depressed and Schizophrenic Patients: How Do They Differ?

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles